Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R …

Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R …
FOXBusiness
“Orphan drug exclusivity confirms Octapharma’s decision to focus exclusively on the treatment of von Willebrand patients. Wilate has a combination of two …
Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R …

 

 
 

Read more news.

en_USEnglish
es_ESEspañol en_USEnglish